Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 15626 - 15650 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Bortezomib	Approved Investigational	ZNRF2	223082	upregulated	Bortezomib results in increased expression of ZNRF2 mRNA	7p14.3	A21434
Bosentan	Approved Investigational	CXADR	1525	downregulated	bosentan results in decreased expression of CXADR mRNA	21q21.1	A21459
Bosentan	Approved Investigational	CYP2B6	1555	upregulated	bosentan results in increased expression of CYP2B6 mRNA	19q13.2	A21460
Bosentan	Approved Investigational	CYP3A4	1576	upregulated	bosentan results in increased expression of CYP3A4 mRNA	7q22.1	A21460
Broxuridine	Investigational	ITGA5	3678	upregulated	Bromodeoxyuridine results in increased expression of ITGA5 mRNA	12q13.13	A21461
Bromocriptine	Approved Investigational Withdrawn	ATF3	467	upregulated	Bromocriptine results in increased expression of ATF3 mRNA	1q32.3	A21462
Bromocriptine	Approved Investigational Withdrawn	HMOX1	3162	upregulated	Bromocriptine results in increased expression of HMOX1 mRNA	22q12.3	A21462
Bromocriptine	Approved Investigational Withdrawn	POMC	5443	upregulated	Bromocriptine results in increased expression of POMC mRNA	2p23.3	A21463
Bryostatin 1	Investigational	BIRC3	330	upregulated	bryostatin 1 results in increased expression of BIRC3 mRNA	11q22.2	A21464
Bryostatin 1	Investigational	IL10	3586	downregulated	bryostatin 1 analog results in decreased expression of IL10 mRNA	1q32.1	A21465
Bryostatin 1	Investigational	IL10	3586	downregulated	bryostatin 1 results in decreased expression of IL10 mRNA	1q32.1	A21465
Bryostatin 1	Investigational	IL12B	3593	downregulated	bryostatin 1 analog results in decreased expression of IL12B mRNA	5q33.3	A21465
Bryostatin 1	Investigational	IL12B	3593	upregulated	bryostatin 1 results in increased expression of IL12B mRNA	5q33.3	A21465
Budesonide	Approved Investigational	CYP3A4	1576	upregulated	[Budesonide results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA	7q22.1	A21466
Budesonide	Approved Investigational	CYP3A4	1576	upregulated	Budesonide results in increased expression of CYP3A4 mRNA	7q22.1	A21467
Budesonide	Approved Investigational	CYP3A5	1577	upregulated	Budesonide results in increased expression of CYP3A5 mRNA	7q22.1	A21030 A21032
Budesonide	Approved Investigational	MT2A	4502	upregulated	Budesonide results in increased expression of MT2A mRNA	16q13	A21468
Budesonide	Approved Investigational	NR3C1	2908	downregulated	Budesonide results in decreased expression of NR3C1 mRNA	5q31.3	A21468
Budesonide	Approved Investigational	SLC51A	200931	upregulated	Budesonide results in increased expression of SLC51A mRNA	3q29	A21467
Budesonide	Approved Investigational	SLC51B	123264	upregulated	Budesonide results in increased expression of SLC51B mRNA	15q22.31	A21467
Bupivacaine	Approved Investigational	PTGS1	5742	upregulated	Bupivacaine results in increased expression of PTGS1 mRNA	9q33.2	A21469
Bupivacaine	Approved Investigational	PTGS2	5743	upregulated	Bupivacaine results in increased expression of PTGS2 mRNA	1q31.1	A21469
Buprenorphine	Approved Illicit Investigational Vet Approved	IL2	3558	downregulated	Buprenorphine results in decreased expression of IL2 mRNA	4q27	A21470
Buprenorphine	Approved Illicit Investigational Vet Approved	IL4	3565	upregulated	Buprenorphine results in increased expression of IL4 mRNA	5q31.1	A21470
Bupropion	Approved Investigational	HMGCS1	3157	upregulated	Bupropion results in increased expression of HMGCS1 mRNA	5p12	A20655

Displaying entries 15626 - 15650 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability